paclitaxel has been researched along with Chemo-Fog in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Beesley, VL; Campbell, R; DeFazio, A; Friedlander, ML; Grant, P; King, MT; Nagle, CM; Obermair, A; Ross, TL; Webb, PM | 1 |
Ahire, C; Balasubramanian, P; Campisi, J; Csipo, T; Csiszar, A; DelFavero, J; Faakye, JA; Gulej, R; Kiss, T; Kuan-Celarier, A; Mukli, P; Nagaraja, R; Nyul-Toth, A; Tang, Q; Tarantini, A; Tarantini, S; Ungvari, A; Ungvari, Z; Yabluchanskiy, A; Yan, F | 1 |
Ehrlich, BE; Fischer, TT; Nguyen, LD | 1 |
3 other study(ies) available for paclitaxel and Chemo-Fog
Article | Year |
---|---|
Evaluating patient-reported symptoms and late adverse effects following completion of first-line chemotherapy for ovarian cancer using the MOST (Measure of Ovarian Symptoms and Treatment concerns).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Carboplatin; Carcinoma, Ovarian Epithelial; Chemotherapy-Related Cognitive Impairment; Chemotherapy, Adjuvant; Cytoreduction Surgical Procedures; Fatigue; Female; Humans; Long Term Adverse Effects; Longitudinal Studies; Middle Aged; Neoadjuvant Therapy; Neoplasms, Cystic, Mucinous, and Serous; Ovarian Neoplasms; Paclitaxel; Patient Reported Outcome Measures; Peripheral Nervous System Diseases; Sleep Initiation and Maintenance Disorders | 2022 |
Accelerated cerebromicrovascular senescence contributes to cognitive decline in a mouse model of paclitaxel (Taxol)-induced chemobrain.
Topics: Animals; Chemotherapy-Related Cognitive Impairment; Cognitive Dysfunction; Disease Models, Animal; Endothelial Cells; Mice; Paclitaxel; Senotherapeutics | 2023 |
Pharmacological rescue of cognitive function in a mouse model of chemobrain.
Topics: Animals; Antineoplastic Agents, Phytogenic; Chemotherapy-Related Cognitive Impairment; Cognition; Disease Models, Animal; Female; Inositol 1,4,5-Trisphosphate Receptors; Lithium Chloride; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Paclitaxel | 2021 |